Commonwealth Equity Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Commonwealth Equity Services’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,984	Closed	-$289K	–	2312
2016 Q2	$289K	Buy	1,984 +87	+5%	+$12.3K	﹤0.01%	1689
2016 Q1	$272K	Sell	1,897 -380	-17%	-$54K	﹤0.01%	1701
2015 Q4	$352K	Sell	2,277 -75	-3%	-$10.9K	﹤0.01%	1496
2015 Q3	$336K	Buy	2,352 +595	+34%	+$83.2K	﹤0.01%	1482
2015 Q2	$252K	Hold	1,757	–	–	﹤0.01%	1760
2015 Q1	$248K	Buy	+1,757	New	+$270K	﹤0.01%	1759

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services's TARO Position: Q3 2016 in Review

Commonwealth Equity Services sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2016, closing a stake of 1,984 shares — an estimated $289K sold.

Commonwealth Equity Services first reported a position in TARO in Q1 2015 and held it in 6 quarters. The position peaked at $352K in Q4 2015. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

Commonwealth Equity Services reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2016 after selling out during the quarter.
Commonwealth Equity Services sold 1,984 Taro Pharmaceutical Industries Ltd. shares in Q3 2016, an estimated $289K.
Commonwealth Equity Services first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 6 quarters.
Commonwealth Equity Services's Taro Pharmaceutical Industries Ltd. position peaked at $352K in Q4 2015.
162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on Commonwealth Equity Services's 13F filing for Q3 2016, filed 25 Oct 2016.